tradingkey.logo

Danaher Corp

DHR
View Detailed Chart
215.370USD
+0.320+0.15%
Close 10/31, 16:00ETQuotes delayed by 15 min
152.12BMarket Cap
43.42P/E TTM

Danaher Corp

215.370
+0.320+0.15%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.15%

5 Days

-3.30%

1 Month

+8.63%

6 Months

+8.05%

Year to Date

-6.18%

1 Year

-11.12%

View Detailed Chart

TradingKey Stock Score of Danaher Corp

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Danaher Corp's Score

Industry at a Glance

Industry Ranking
57 / 210
Overall Ranking
138 / 4621
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 25 analysts
Buy
Current Rating
254.210
Target Price
+18.78%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Danaher Corp Highlights

StrengthsRisks
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 20.13%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 20.13%.
Overvalued
The company’s latest PE is 44.04, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 590.97M shares, decreasing 0.57% quarter-over-quarter.
Held by Al Gore
Star Investor Al Gore holds 4.97M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.06.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Danaher Corp Info

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Ticker SymbolDHR
CompanyDanaher Corp
CEOMr. Rainer M. Blair
Websitehttps://www.danaher.com/
KeyAI